PL4138585T3 - Formulacja ulegająca aerozolowaniu - Google Patents

Formulacja ulegająca aerozolowaniu

Info

Publication number
PL4138585T3
PL4138585T3 PL21724355.9T PL21724355T PL4138585T3 PL 4138585 T3 PL4138585 T3 PL 4138585T3 PL 21724355 T PL21724355 T PL 21724355T PL 4138585 T3 PL4138585 T3 PL 4138585T3
Authority
PL
Poland
Prior art keywords
aerosolisable formulation
aerosolisable
formulation
Prior art date
Application number
PL21724355.9T
Other languages
English (en)
Inventor
Andrew Burton
George Mclachlan
Connor BRUTON
Anna Azzopardi
Olatunde AKANDE
Victoria MCKEOWN
Jay Morris
Paulo AGUIAR
Peter Clayton
Maria Montserrat Sanchez Pena
Original Assignee
Nicoventures Trading Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoventures Trading Limited filed Critical Nicoventures Trading Limited
Publication of PL4138585T3 publication Critical patent/PL4138585T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL21724355.9T 2020-04-24 2021-04-23 Formulacja ulegająca aerozolowaniu PL4138585T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2006008.3A GB202006008D0 (en) 2020-04-24 2020-04-24 Aerosolisable formulation
PCT/GB2021/050997 WO2021214491A1 (en) 2020-04-24 2021-04-23 Aerosolisable formulation

Publications (1)

Publication Number Publication Date
PL4138585T3 true PL4138585T3 (pl) 2024-07-15

Family

ID=71080277

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21724355.9T PL4138585T3 (pl) 2020-04-24 2021-04-23 Formulacja ulegająca aerozolowaniu

Country Status (6)

Country Link
US (1) US20230144701A1 (pl)
EP (1) EP4138585B1 (pl)
GB (1) GB202006008D0 (pl)
MX (1) MX2022013096A (pl)
PL (1) PL4138585T3 (pl)
WO (1) WO2021214491A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118766127A (zh) * 2023-04-03 2024-10-15 思摩尔国际控股有限公司 一种多组分复配尼古丁制剂及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016341443A1 (en) * 2015-10-23 2018-06-07 Next Generation Labs, LLC Nicotine composition for vaping devices and vaping devices employing the same
JP2019502756A (ja) 2015-12-30 2019-01-31 ネクスト・ジェネレーション・ラブズ・エルエルシーNext Generation Labs, Llc 合成ニコチンを含むニコチン置換療法製品
KR102698646B1 (ko) * 2016-02-01 2024-08-27 필립모리스 프로덕츠 에스.에이. 다수의 전력 공급부를 갖는 에어로졸 발생 장치
CN106770809B (zh) * 2017-03-15 2019-10-11 上海烟草集团有限责任公司 一种电子烟烟液中烟碱手性异构体的分析方法
AU2019255322A1 (en) * 2018-04-17 2020-11-05 Poviva Corp. Lipophilic active agent infused compositions with reduced food effect

Also Published As

Publication number Publication date
EP4138585B1 (en) 2024-02-21
MX2022013096A (es) 2022-12-08
US20230144701A1 (en) 2023-05-11
CA3172538A1 (en) 2021-10-28
EP4138585A1 (en) 2023-03-01
GB202006008D0 (en) 2020-06-10
WO2021214491A1 (en) 2021-10-28

Similar Documents

Publication Publication Date Title
GB201718035D0 (en) Aerosolisable formulation
GB202312220D0 (en) Formulation
GB202308224D0 (en) Formulation
GB202007546D0 (en) Formulation
IL307849A (en) Sutorsive formulation
GB202307002D0 (en) Cannabinoid-based formulation
GB202108165D0 (en) Formulation
GB202102636D0 (en) Formulation
GB202006008D0 (en) Aerosolisable formulation
IL308046A (en) Alflizib formulation
GB202107439D0 (en) Formulation
GB202107203D0 (en) Formulation
GB202103970D0 (en) Formulation
GB202102408D0 (en) Formulation
GB202016274D0 (en) Formulation
GB202010573D0 (en) Formulation
PL4312993T3 (pl) Preparat zawierający ceralasertyb
GB202005340D0 (en) Formulation
GB202003048D0 (en) Formulation
GB2599912B (en) New formulation
GB202115303D0 (en) New formulation
GB202108181D0 (en) New formulation
GB2595453B (en) Novel Formulation
GB2595301B (en) Novel Formulation
GB2595300B (en) Novel Formulation